Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
FATE · NASDAQ · Biological Products, (No Diagnostic Substances)
$0.919−0.091 (−9.01%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Fate Therapeutics (FATE) · oqro.io/stocks/FATE · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake, activist · Stake as of Nov 5, 2026 · Filed Nov 9, 2026
Redmile Group, LLC disclosed a 15.0% stake in FATE and may seek to influence the companySourceInsider trade · Traded Nov 3, 2026 · Filed Nov 4, 2026
CFO sold ~$14K of FATE shares in the open marketSourcePlanned sale · Planned for Nov 3, 2026 · Notice filed Nov 3, 2026
Officer filed to sell about $14K of FATE stockSourceInsider trade · Traded Aug 4, 2025 · Filed Aug 5, 2025
CEO sold ~$15K of FATE shares in the open marketSourceInsider trade · Traded Aug 4, 2025 · Filed Aug 5, 2025
Officer sold ~$9.6K of FATE shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deep Track Capital, LP no longer reported FATE for Q4 2024SourceInsider trade · Traded Jan 10, 2025 · Filed Jan 13, 2025
CEO sold ~$13K of FATE shares in the open marketSourceInsider trade · Traded Jan 10, 2025 · Filed Jan 13, 2025
Officer sold ~$8.8K of FATE shares in the open marketSourceInsider trade · Traded Jan 10, 2025 · Filed Jan 13, 2025
Officer sold ~$9.3K of FATE shares in the open marketSourceInsider trade · Traded Dec 20, 2024 · Filed Dec 27, 2024
Director purchased ~$669K of FATE shares in the open marketSourceInsider trade · Traded Dec 20, 2024 · Filed Dec 27, 2024
Director sold ~$574K of FATE shares in the open marketSourcePolitician trade (House) · Transaction Jan 31, 2023 · Disclosed Feb 24, 2023
Disclosed sale of FATE — reported range $1,001 - $15,000Source